Stock research
Invesco Ltd. (IVZ) Stock Research
Invesco is an asset manager offering mutual funds and ETFs, including the popular QQQ fund.
Invesco Ltd. reported revenue of $6.4B for the fiscal year ended December 31, 2025 and net income of $538M for the fiscal year ended December 31, 2024. Source: Form 10-K filed February 24, 2026
SEC data as of
- Revenue
- $6.4B
- FY ending 2025-12-31
- Net income
- $538M
- FY ending 2024-12-31
- Diluted EPS
- −$1.60
- Sector
- Financials
Reported SEC XBRL figures. Each metric’s period and original filing are listed below.
Delayed Cboe One market data via TradingView. It may differ from primary-exchange or consolidated quotes.
About Invesco
- Exchange
- NYSE: IVZ
- Sector
- Financials
- SEC industry
- Investment Advice (SIC 6282)
- Fiscal year end
- December 31
IVZ key financials
Reported figures from Invesco Ltd.'s filings, pulled directly from SEC XBRL data rather than a third-party terminal. Each row links to the filing it came from.
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $6.4B | 2025-01-01 – 2025-12-31 | SEC filing |
| Net income | $538M | 2024-01-01 – 2024-12-31 | SEC filing |
| Operating cash flow | $1.5B | 2025-01-01 – 2025-12-31 | SEC filing |
| Diluted EPS | −$1.60 | 2025-01-01 – 2025-12-31 | SEC filing |
| Shares outstanding | 444M | As of 2026-01-31 | SEC filing |
Values are as tagged by the issuer in XBRL. Revenue for banks and insurers is net of interest expense where that is the reported line. Fiscal years that do not follow the calendar are shown by their period-end date. No price, market cap, or valuation multiple is shown because Yield Theory does not republish unlicensed market data.
Diluted EPS is the earnings figure behind the price-to-earnings ratio; the P/E multiple compression calculator shows how a change in that multiple moves a share price. Shares outstanding multiplied by the share price gives market capitalization.
What investors should watch in IVZ
Invesco Ltd. sits in Financials. Banks, insurers, asset managers, and exchanges — the plumbing of capital markets, geared directly to interest rates and credit. We have not yet written company-specific drivers for IVZ; the forces that matter most for the sector are:
- ◆The shape of the yield curve and net interest margins
- ◆Credit quality and loan-loss provisions
- ◆Regulation and capital requirements
- ◆Deal activity and market volatility
IVZ primary sources
- Latest annual report: Form 10-K filed February 24, 2026
- Latest quarterly report: Form 10-Q filed August 4, 2026
- All IVZ filings on SEC EDGAR
How we source and review company pages: research methodology.
Congressional trading in IVZ
| Politician | Trade date | Type | Owner | Amount | Source |
|---|---|---|---|---|---|
| Kevin Hern | 2026-03-17 | Sale | Joint | $15,001 - $50,000 | Filing #20034262 |
| Gilbert Cisneros | 2026-02-10 | Sale | Self | $1,001 - $15,000 | Filing #20034144 |
| Gilbert Cisneros | 2026-01-09 | Purchase | Self | $1,001 - $15,000 | Filing #20033983 |
| Robert Bresnahan | 2025-04-08 | Sale | Self | $1,001 - $15,000 | Filing #20030238 |
All verified IVZ congressional disclosures
Congressional disclosures are delayed, range-based records—not real-time signals or proof of motive. See the source-linked tracker for scope and limitations.
Compare IVZ with similar companies
Invesco peers
IVZ — frequently asked questions
What does Invesco Ltd. do?
Invesco is an asset manager offering mutual funds and ETFs, including the popular QQQ fund.
What were IVZ's latest reported annual revenue and net income?
Invesco Ltd. reported revenue of $6.4B for the fiscal year ended December 31, 2025 and net income of $538M for the fiscal year ended December 31, 2024. The figures come from Invesco Ltd.'s SEC XBRL filings.
When does Invesco Ltd.'s fiscal year end?
The SEC lists Invesco Ltd.'s fiscal year end as December 31.
Do members of Congress trade IVZ?
The current verified House and Senate snapshot contains 4 transaction rows for IVZ, each linked to the original filing.
Is IVZ a good investment?
This page does not rate IVZ as a buy or sell. It sets out what Invesco Ltd. reports, what investors should watch and the questions a thesis has to answer, with links to the SEC filings. It is research, not investment advice.
This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.
What do the IVZ numbers leave unanswered?
Financials describe the business. The next question is which assumptions an investment thesis depends on. Explore the member reports below for analysis of catalysts, risks, and what would change the view. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included